SEC Form 4/A · accession 0001140361-16-077244
BLONDER TONGUE LABORATORIES INC · BDR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Robert J Palle Jr.
Officer — President and CEO · Director · 10% Owner
Period of report
Dec 10, 2015
Accepted (ET)
Aug 19, 2016 · 1:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001000683
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2,F1,F3 | $0.395 | Dec 10, 2015 | A | 100,000 | A | — | Dec 10, 2025 | Common Stock, par value $0.001 | 100,000 | 100,000 | D |
Explanation of responses
- F1The exercise price equals the fair market value (equal to the average of the high and low selling prices as reported on the NYSE MKT) of the common stock on the grant date.
- F2The number of derivative securities reflects the cancellation of 150,000 of the 250,000 shares originally underlying the stock option.
- F3The stock option vested immediately on the date of grant.